(A21.2) Pulmonary tularaemia

More details coming soon

Icon
25 757 in individuals diagnosis pulmonary tularaemia confirmed
Icon
1 928 deaths with diagnosis pulmonary tularaemia
Icon
8% mortality rate associated with the disease pulmonary tularaemia

Diagnosis pulmonary tularaemia is diagnosed Men are 23.00% more likely than Women

15 840

Men receive the diagnosis pulmonary tularaemia

1 928 (12.2 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
9 917

Women receive the diagnosis pulmonary tularaemia

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease pulmonary tularaemia - Men aged 60-64 and Women aged 65-69

Icon
In Men diagnosis is most often set at age 0-84
Icon
Less common in men the disease occurs at Age 0-1, 85-95+Less common in women the disease occurs at Age 0-1, 20-24, 80-84, 90-95+
Icon
In Women diagnosis is most often set at age 0-19, 25-79, 85-89

Disease Features pulmonary tularaemia

Icon
Absence or low individual and public risk
Icon

Pulmonary tularaemia - what does this mean

Pulmonary tularaemia is a rare form of tularaemia caused by inhalation of the bacteria francisella tularensis. it is characterized by fever, chest pain, and coughing up of bloody sputum. it can be fatal if not treated promptly with antibiotics.

What happens during the disease - pulmonary tularaemia

Pulmonary tularaemia is an infectious disease caused by the bacterium francisella tularensis. it is usually transmitted through contact with infected animals or their secretions, or by inhalation of contaminated dust or aerosols. the bacteria invades the lungs, causing inflammation and damage to the alveolar walls and leading to symptoms such as fever, chest pain, coughing, and difficulty breathing. in some cases, the infection can spread to other organs, leading to more serious complications.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Blood tests to detect the presence of antibodies to the bacteria
  • Chest X-ray
  • Sputum culture
  • Bronchoscopy
  • Lung biopsy
  • CT scan
  • Pulmonary function tests
  • Lung fluid analysis
Additions:
  • Serological tests
  • Immunofluorescence test

Treatment and Medical Assistance

Main goal of the treatment: To reduce the severity of the symptoms and to prevent the spread of the disease.
  • Administering antibiotics, such as Streptomycin, to reduce the severity of the symptoms.
  • Prescribing anti-inflammatory medications to reduce the inflammation caused by the infection.
  • Providing supportive care, such as oxygen and fluids, to help manage the symptoms of the disease.
  • Conducting regular follow-up exams to monitor the progress of the disease.
  • Educating patients about the importance of good hygiene and the proper use of antibiotics.
  • Implementing measures to prevent the spread of the disease, such as isolating infected individuals and using protective equipment when caring for them.
Icon
16 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Pulmonary tularaemia - Prevention

Pulmonary tularaemia can be prevented by avoiding contact with infected animals, such as rabbits and hares, and by avoiding activities that could expose one to contaminated soil or water. vaccination is recommended for people at high risk of exposure, such as hunters and laboratory workers. it is also important to practice good hand hygiene and wear protective clothing when handling animals or in areas where the disease is known to be present.